SCHEMBL22947445

SCHEMBL22947445

c1ccc(-c2ccc(-c3ccc4oc5cc(-c6c7ccccc7c(-c7ccccc7)c7ccccc67)ccc5c4c3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.47
PLA2G4A P47712 4/20 0.47
MMP12 P39900 1/20 0.43
MMP13 P45452 1/20 0.43
MEN1 O00255 4/20 0.42
MAPT P10636 4/20 0.42
KMT2A Q03164 4/20 0.42
KDM4E B2RXH2 3/20 0.42
AHR P35869 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PLA2G10 O15496 1/20 0.41
HCRTR1 O43613 1/20 0.39
PGR P06401 1/20 0.38
PRKDC P78527 3/20 0.38
ATM Q13315 1/20 0.38
GAA P10253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26404346 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL27011528 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL20363681 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL23427718 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL18382827 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL23426921 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL20109941 1.00 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL22178612 0.98 PLA2G2A (0.49) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL25624640 0.98 PLA2G2A (0.46) PLA2G2APLA2G4AMMP12MMP13MEN1
SCHEMBL23426534 0.98 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 US disclosed
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 US disclosed
EP-4119634-B1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SFC CO LTD (KR) 2023-09-20 EP disclosed
EP-4119634-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SFC Co., Ltd. (KR) 2023-01-18 EP disclosed
US-11482676-B2 Light emitting diode including boron compound SFC CO., LTD. (KR) 2022-10-25 US disclosed
US-20220123219-A1 COMPOUND FOR ORGANIC LIGHT EMITTING ELEMENT, AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME AND HAVING LONG LIFESPAN SFC CO., LTD. (KR) 2022-04-21 US disclosed
EP-3792989-A1 ORGANIC LIGHT EMITTING DIODE INCLUDING BORON COMPOUNDS SFC Co., Ltd. (KR) 2021-03-17 EP disclosed
US-20210036233-A1 LIGHT EMITTING DIODE INCLUDING BORON COMPOUND SFC CO., LTD. (KR) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME PPOX, MAP1LC3A, VDAC2 PLA2G2A 1893/4885PLA2G4A 1054/4885MMP12 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.